Sentinel lymph node biopsy using methylene blue-fluorescein dye combination in post neo-adjuvant chemotherapy node negative (ycN0) breast cancer patients: A validation study. (2026)

Peer-Reviewed Study · Mishra M, Singh PK, Jha CK, Sinha U, Kumar T · November 5, 2026

Mishra M et al., 2026-11-05: Indian study of a methylene blue plus fluorescein dye combination as a low-cost substitute for radiocolloid dual-tracer sentinel node biopsy after neoadjuvant chemotherapy.

We evaluated a combination of methylene blue and fluorescein dyes as a low-cost alternative.

Mishra M et al., 2026-11-05: Indian study of a methylene blue plus fluorescein dye combination as a low-cost substitute for radiocolloid dual-tracer sentinel node biopsy after neoadjuvant chemotherapy. C7. Study type: prospective evaluation (Trop Doct 2026, online-first article 494755261503380); All India Institute of Medical Sciences, India. N not stated in the abstract text captured; the abstract is a three-sentence summary with no results. Countries where radiocolloid is unavailable are the stated rationale. Methylene blue concentration/dose, funder and conflicts not stated in the abstract. Confidence MEDIUM because the abstract carries no outcome numbers. Study type: uncontrolled series.